Liver Fibrosis Series
Liver fibrosis testing is a non-invasive assessment method that helps doctors diagnose liver fibrosis early, evaluate its severity, monitor the progression of liver fibrosis, and timely detect and intervene in disease deterioration, preventing liver disease from progressing to decompensated cirrhosis. The results of liver fibrosis testing guide clinical diagnosis and treatment, enabling doctors to develop personalized treatment plans based on the degree of liver fibrosis, adjust lifestyle and treatment measures, and reduce disease risk. The degree of liver fibrosis is an important indicator for predicting the severity and prognosis of chronic liver disease. Hyaluronic acid (HA) and laminin (LN) can accurately and sensitively reflect the amount of intrahepatic fibrosis, the condition of liver cell damage, and the activity level of liver fibrosis, which is positively correlated with portal vein pressure, thereby enhancing the specificity and effectiveness of treatment.